Personal information

Other IDs

Loop profile: 1900535

Activities

Collapse all

Works (9)

Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers

Cells
2024-12-17 | Journal article
DOI: 10.3390/cells13242087
Contributors: Sara Manore; Chuling Zhuang; Mariana K. Najjar; Grace L. Wong; Shivani Bindal; Kounosuke Watabe; Jiayuh Lin; Hui-Wen Lo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Interleukin-1 Receptor-Associated Kinase 1 in Cancer Metastasis and Therapeutic Resistance: Mechanistic Insights and Translational Advances

Cells
2024-10-12 | Journal article
DOI: 10.3390/cells13201690
Contributors: Mariana K. Najjar; Munazza S. Khan; Chuling Zhuang; Ankush Chandra; Hui-Wen Lo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers

Cancer Letters
2024-08 | Journal article
DOI: 10.1016/j.canlet.2024.217023
Contributors: Angelina T. Regua; Shivani Bindal; Mariana K. Najjar; Chuling Zhuang; Munazza Khan; Austin B.J. Arrigo; Anneliese O. Gonzalez; Xinhai R. Zhang; Jay-Jiguang Zhu; Kounosuke Watabe et al.
Source: check_circle
Crossref

Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis

Frontiers in Oncology
2024-08-08 | Journal article
DOI: 10.3389/fonc.2024.1436942
Part of ISSN: 2234-943X
Contributors: Munazza S. Khan; Grace L. Wong; Chuling Zhuang; Mariana K. Najjar; Hui-Wen Lo
Source: Self-asserted source
Mariana Najjar via Crossref Metadata Search

Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy

Cancers
2023-04 | Journal article | Author
DOI: 10.3390/cancers15092455
Contributors: Austin Arrigo; Angelina Regua; Mariana Najjar; Hui-Wen Lo
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer

Genes
2022-11-08 | Journal article
DOI: 10.3390/genes13112065
Contributors: Mariana K. Najjar; Sara G. Manore; Angelina T. Regua; Hui-Wen Lo
Source: check_circle
Crossref

An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1

Cancers
2022-08-31 | Journal article
DOI: 10.3390/cancers14174256
Contributors: Daniel Doheny; Sara Manore; Sherona R. Sirkisoon; Dongqin Zhu; Noah R. Aguayo; Alexandria Harrison; Mariana Najjar; Marlyn Anguelov; Anderson O’Brien Cox; Cristina M. Furdui et al.
Source: check_circle
Crossref

RET signaling pathway and RET inhibitors in human cancer

Frontiers in Oncology
2022-07-25 | Journal article
DOI: 10.3389/fonc.2022.932353
Part of ISSN: 2234-943X
Contributors: Angelina T. Regua; Mariana Najjar; Hui-Wen Lo
Source: Self-asserted source
Mariana Najjar

The Effects of Neopterin on the Viability and Motility of Different HCC Cell Lines

The 2nd International Cell Death Research Congress
2018-12-06 | Journal article
DOI: 10.3390/proceedings2251581
Contributors: Imge Kunter; Marianna Najjar; Yelin Subasi; Niloofar Zabib; Gonul Sahin; Mariana Najjar
Source: Self-asserted source
Mariana Najjar
How many people are using ORCID?